Large-scale testing (Phase 3)Study completedNCT03095456
What this trial is testing
Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
Who this might be right for
Chronic Obstructive Pulmonary Disease, COPDLow Peak Inspiratory Flow Rate (PIFR)
Mylan Inc. 207